{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:18:43Z","timestamp":1776748723793,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7699","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/nature26157","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T10:46:53Z","timestamp":1522147613000},"page":"103-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":380,"title":["A new class of synthetic retinoid antibiotics effective against bacterial persisters"],"prefix":"10.1038","volume":"556","author":[{"given":"Wooseong","family":"Kim","sequence":"first","affiliation":[]},{"given":"Wenpeng","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Gabriel Lambert","family":"Hendricks","sequence":"additional","affiliation":[]},{"given":"Daria","family":"Van Tyne","sequence":"additional","affiliation":[]},{"given":"Andrew D.","family":"Steele","sequence":"additional","affiliation":[]},{"given":"Colleen E.","family":"Keohane","sequence":"additional","affiliation":[]},{"given":"Nico","family":"Fricke","sequence":"additional","affiliation":[]},{"given":"Annie L.","family":"Conery","sequence":"additional","affiliation":[]},{"given":"Steven","family":"Shen","sequence":"additional","affiliation":[]},{"given":"Wen","family":"Pan","sequence":"additional","affiliation":[]},{"given":"Kiho","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Rajmohan","family":"Rajamuthiah","sequence":"additional","affiliation":[]},{"given":"Beth Burgwyn","family":"Fuchs","sequence":"additional","affiliation":[]},{"given":"Petia M.","family":"Vlahovska","sequence":"additional","affiliation":[]},{"given":"William M.","family":"Wuest","sequence":"additional","affiliation":[]},{"given":"Michael S.","family":"Gilmore","sequence":"additional","affiliation":[]},{"given":"Huajian","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Frederick M.","family":"Ausubel","sequence":"additional","affiliation":[]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"BFnature26157_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10069","volume":"473","author":"KR Allison","year":"2011","unstructured":"Allison, K. R., Brynildsen, M. P. & Collins, J. J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473, 216\u2013220 (2011)","journal-title":"Nature"},{"key":"BFnature26157_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature12790","volume":"503","author":"BP Conlon","year":"2013","unstructured":"Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365\u2013370 (2013)","journal-title":"Nature"},{"key":"BFnature26157_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"J Davies","year":"2010","unstructured":"Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417\u2013433 (2010)","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"BFnature26157_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","volume":"364","author":"DP Lew","year":"2004","unstructured":"Lew, D. P. & Waldvogel, F. A. Osteomyelitis. Lancet 364, 369\u2013379 (2004)","journal-title":"Lancet"},{"key":"BFnature26157_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour, L. M. et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132, 1435\u20131486 (2015)","journal-title":"Circulation"},{"key":"BFnature26157_CR6","doi-asserted-by":"publisher","first-page":"e89189","DOI":"10.1371\/journal.pone.0089189","volume":"9","author":"R Rajamuthiah","year":"2014","unstructured":"Rajamuthiah, R. et al. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus. PLoS ONE 9, e89189 (2014)","journal-title":"PLoS ONE"},{"key":"BFnature26157_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nrd2397","volume":"6","author":"L Altucci","year":"2007","unstructured":"Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R. & Gronemeyer, H. RAR and RXR modulation in cancer and metabolic disease. Nat. Rev. Drug Discov. 6, 793\u2013810 (2007)","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnature26157_CR8","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1158\/1535-7163.MCT-08-0419","volume":"7","author":"C Valli","year":"2008","unstructured":"Valli, C. et al. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity. Mol. Cancer Ther. 7, 2941\u20132954 (2008)","journal-title":"Mol. Cancer Ther."},{"key":"BFnature26157_CR9","doi-asserted-by":"publisher","first-page":"8907","DOI":"10.1073\/pnas.1404828111","volume":"111","author":"X-H Tang","year":"2014","unstructured":"Tang, X.-H. et al. Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide. Proc. Natl Acad. Sci. USA 111, 8907\u20138912 (2014)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature26157_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nchembio.2082","volume":"12","author":"T Han","year":"2016","unstructured":"Han, T. et al. The antitumor toxin CD437 is a direct inhibitor of DNA polymerase \u03b1. Nat. Chem. Biol. 12, 511\u2013515 (2016)","journal-title":"Nat. Chem. Biol."},{"key":"BFnature26157_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jadohealth.2008.06.005","volume":"43","author":"CE Irby","year":"2008","unstructured":"Irby, C. E., Yentzer, B. A. & Feldman, S. R. A review of adapalene in the treatment of acne vulgaris. J. Adolesc. Health 43, 421\u2013424 (2008)","journal-title":"J. Adolesc. Health"},{"key":"BFnature26157_CR12","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1128\/AAC.00209-07","volume":"51","author":"M Meehl","year":"2007","unstructured":"Meehl, M., Herbert, S., G\u00f6tz, F. & Cheung, A. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51, 2679\u20132689 (2007)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature26157_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/IAI.05669-11","volume":"80","author":"S-J Yang","year":"2012","unstructured":"Yang, S.-J. et al. The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides. Infect. Immun. 80, 74\u201381 (2012)","journal-title":"Infect. Immun."},{"key":"BFnature26157_CR14","doi-asserted-by":"publisher","first-page":"e1001119","DOI":"10.1371\/journal.pgen.1001119","volume":"6","author":"M Elbaz","year":"2010","unstructured":"Elbaz, M. & Ben-Yehuda, S. The metabolic enzyme ManA reveals a link between cell wall integrity and chromosome morphology. PLoS Genet. 6, e1001119 (2010)","journal-title":"PLoS Genet."},{"key":"BFnature26157_CR15","doi-asserted-by":"publisher","first-page":"e21323","DOI":"10.1371\/journal.pone.0021323","volume":"6","author":"M Falord","year":"2011","unstructured":"Falord, M., M\u00e4der, U., Hiron, A., D\u00e9barbouill\u00e9, M. & Msadek, T. Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways. PLoS ONE 6, e21323 (2011)","journal-title":"PLoS ONE"},{"key":"BFnature26157_CR16","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1128\/AAC.00286-11","volume":"55","author":"N G\u00f6hring","year":"2011","unstructured":"G\u00f6hring, N. et al. New role of the disulfide stress effector YjbH in \u03b2-lactam susceptibility of Staphylococcus aureus. Antimicrob. Agents Chemother. 55, 5452\u20135458 (2011)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature26157_CR17","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1128\/AAC.44.8.2086-2092.2000","volume":"44","author":"CL Friedrich","year":"2000","unstructured":"Friedrich, C. L., Moyles, D., Beveridge, T. J. & Hancock, R. E. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44, 2086\u20132092 (2000)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature26157_CR18","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1021\/bi500779g","volume":"53","author":"Y-F Chen","year":"2014","unstructured":"Chen, Y.-F., Sun, T.-L., Sun, Y. & Huang, H. W. Interaction of daptomycin with lipid bilayers: a lipid extracting effect. Biochemistry 53, 5384\u20135392 (2014)","journal-title":"Biochemistry"},{"key":"BFnature26157_CR19","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1039\/c4sc00034j","volume":"5","author":"MS Ganewatta","year":"2014","unstructured":"Ganewatta, M. S. et al. Bio-inspired resin acid-derived materials as anti-bacterial resistance agents with unexpected activities. Chem. Sci. 5, 2011\u20132016 (2014)","journal-title":"Chem. Sci."},{"key":"BFnature26157_CR20","doi-asserted-by":"publisher","first-page":"13381","DOI":"10.1021\/jp207013v","volume":"115","author":"TJ Piggot","year":"2011","unstructured":"Piggot, T. J., Holdbrook, D. A. & Khalid, S. Electroporation of the E. coli and S. aureus membranes: molecular dynamics simulations of complex bacterial membranes. J. Phys. Chem. B 115, 13381\u201313388 (2011)","journal-title":"J. Phys. Chem. B"},{"key":"BFnature26157_CR21","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1016\/j.jchromb.2009.08.001","volume":"877","author":"F Sala","year":"2009","unstructured":"Sala, F. et al. Development and validation of a liquid chromatography\u2013tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study. J. Chromatogr. B 877, 3118\u20133126 (2009)","journal-title":"J. Chromatogr. B"},{"key":"BFnature26157_CR22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.chembiol.2013.07.006","volume":"20","author":"MA Farha","year":"2013","unstructured":"Farha, M. A., Verschoor, C. P., Bowdish, D. & Brown, E. D. Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus. Chem. Biol. 20, 1168\u20131178 (2013)","journal-title":"Chem. Biol."},{"key":"BFnature26157_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrmicro2474","volume":"9","author":"JG Hurdle","year":"2011","unstructured":"Hurdle, J. G., O\u2019Neill, A. J., Chopra, I. & Lee, R. E. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9, 62\u201375 (2011)","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnature26157_CR24","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.29886","volume":"138","author":"H Basma","year":"2016","unstructured":"Basma, H. et al. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma. Int. J. Cancer 138, 1528\u20131537 (2016)","journal-title":"Int. J. Cancer"},{"key":"BFnature26157_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/597031","volume":"48","author":"SE Cosgrove","year":"2009","unstructured":"Cosgrove, S. E. et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin. Infect. Dis. 48, 713\u2013721 (2009)","journal-title":"Clin. Infect. Dis."},{"key":"BFnature26157_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/cr400126u","volume":"114","author":"R \u00c1lvarez","year":"2014","unstructured":"\u00c1lvarez, R., Vaz, B., Gronemeyer, H. & de Lera, A. R. Functions, therapeutic applications, and synthesis of retinoids and carotenoids. Chem. Rev. 114, 1\u2013125 (2014)","journal-title":"Chem. Rev."},{"key":"BFnature26157_CR27","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1083\/jcb.135.6.1889","volume":"135","author":"D Schadendorf","year":"1996","unstructured":"Schadendorf, D. et al. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol. 135, 1889\u20131898 (1996)","journal-title":"J. Cell Biol."},{"key":"BFnature26157_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s002800050841","volume":"42","author":"SP Langdon","year":"1998","unstructured":"Langdon, S. P. et al. Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo. Cancer Chemother. Pharmacol. 42, 429\u2013432 (1998)","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnature26157_CR29","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood.V95.8.2672","volume":"95","author":"I Ponzanelli","year":"2000","unstructured":"Ponzanelli, I. et al. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid. Blood 95, 2672\u20132682 (2000)","journal-title":"Blood"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature26157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature26157","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature26157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature26157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:13:08Z","timestamp":1684419188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature26157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":29,"journal-issue":{"issue":"7699","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["BFnature26157"],"URL":"https:\/\/doi.org\/10.1038\/nature26157","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732909342.793545839","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732909342.793545020","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"31 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.M.A. and E.M. have interests in Genma Biosciences, Inc. and Octagon Therapeutics, Inc., companies that are engaged in developing antimicrobial compounds. The interests of E.M. and F.M.A. were reviewed and are managed by Rhode Island Hospital (E.M.) and Massachusetts General Hospital and Partners HealthCare (F.M.A.) in accordance with their conflict of interest policies. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}